10 Best “Strong Buy” Stocks — AOL OCN PHM and more

by Portfolio Grader | November 21, 2012 8:00 pm

10 Best “Strong Buy” Stocks — AOL OCN PHM and more

This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader[1], have the best year-to-date performance. Since the beginning of the year, the Nasdaq rose 10.1%, the Dow is up 4.7%, and the S&P is up 10.3%.

Since January 1, the price of AOL Inc (NYSE:AOL[2]) has grown 132.5%. AOL provides online content, products, and services to consumers, publishers, and advertisers worldwide. The stock has a trailing PE Ratio of 3.30. For more information, get Portfolio Grader’s complete analysis of AOL stock[3].

Shares of Ocwen Financial (NYSE:OCN[4]) have leapt 135.9% since January 1. Ocwen Financial is diversified financial services holding company. For more information, get Portfolio Grader’s complete analysis of OCN stock[5].

The price of PulteGroup (NYSE:PHM[6]) has seen a 165.4% boost since the first of the year. PulteGroup sells and constructs homes, and purchases, develops, and sells residential land and develops active adult communities. For more information, get Portfolio Grader’s complete analysis of PHM stock[7].

Shares of Mellanox Technologies (NASDAQ:MLNX[8]) have risen 160% since January 1. Mellanox designs and develops semiconductor-based, high-performance interconnect products. For more information, get Portfolio Grader’s complete analysis of MLNX stock[9].

Since January 1, Nam Tai Electronics (NYSE:NTE[10]) has jumped 163%. Nam Tai Electronics is an electronics design and manufacturing services provider to original equipment manufacturers. For more information, get Portfolio Grader’s complete analysis of NTE stock[11].

Since January 1, 3D Systems (NYSE:DDD[12]) has shot up 186%. 3D Systems engages in the design, development, manufacture, marketing, and servicing of 3D printers and related products, print materials, and services. For more information, get Portfolio Grader’s complete analysis of DDD stock[13].

Since the first of the year, shares of Santarus (NASDAQ:SNTS[14]) have soared 184%. Santarus, Inc. was incorporated in California in December 1996 and reincorporated in Delaware in July 2002. It is a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists and other targeted physicians. For more information, get Portfolio Grader’s complete analysis of SNTS stock[15].

Regeneron Pharmaceuticals (NASDAQ:REGN[16]) has risen 211% since the first of the year. Regeneron Pharmaceuticals researches, develops and commercializes therapeutics to treat human disorders and conditions. For more information, get Portfolio Grader’s complete analysis of REGN stock[17].

Since January 1, Lumber Liquidators (NYSE:LL[18]) has climbed 209%. Lumber Liquidators retails hardwood flooring in the United States. For more information, get Portfolio Grader’s complete analysis of LL stock[19].

The price of Pharmacyclics (NASDAQ:PCYC[20]) is up 250% since the first of the year. Pharmacyclics is a pharmaceutical company developing products to improve upon current therapeutic approaches to cancer, atherosclerosis, and retinal disease. For more information, get Portfolio Grader’s complete analysis of PCYC stock[21].

Louis Navellier’s proprietary Portfolio Grader[1] stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here[22].